tbuckley/cabot-search huggingface dataset:
Altered selection on a single self-ligand promotes susceptibility to organ-specific T cell infiltration
Authors: David E.J. Klawon, Dana C. Gilmore, John D. Leonard, Christine H. Miller, Jaime L. Chao, Matthew T. Walker, Ryan K. Duncombe, Kenneth S. Tung, Erin J. Adams, Peter A. Savage
Journal: The Journal of Experimental Medicine (2021)

For the large array of self-peptide/MHC class II (pMHC-II) complexes displayed in the body, it is unclear whether CD4+ T cell tolerance must be imparted for each individual complex or whether pMHC-II–nonspecific bystander mechanisms are sufficient to confer tolerance by acting broadly on T cells reactive to multiple self-pMHC-II ligands. Here, via reconstitution of T cell–deficient mice, we demonstrate that altered T cell selection on a single prostate-specific self-pMHC-II ligand renders recipient mice susceptible to prostate-specific T cell infiltration. Mechanistically, this self-pMHC-II complex is required for directing antigen-specific cells into the Foxp3+ regulatory T cell lineage but does not induce clonal deletion to a measurable extent. Thus, our data demonstrate that polyclonal T reg cells are unable to functionally compensate for a breach in tolerance to a single self-pMHC-II complex in this setting, revealing vulnerabilities in antigen-nonspecific bystander mechanisms of immune tolerance.
UTILIZATION OF PALLIATIVE CARE CONSULTS IN PATIENTS WITH HEART FAILURE
Authors: Prashanth Singanallur, Yasser Al-Khadra, Radhika Deshpande, Basma Al-bast, Venkata Missula, Manasik Abdu, Nour Albast, Raad Al Tamimi, Abhishek Kulkarni, Kalyan Potu
Journal: Journal of the American College of Cardiology (2021)
Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants
Authors: Jennifer Abbasi
Journal: JAMA (2021)

Brian J. Boyarsky, MD; William A. Werbel, MD; Robin K. Avery, MD; Aaron A. R. Tobian, MD, PhD; Allan B. Massie, PhD; Dorry L. Segev, MD, PhD; Jacqueline M. Garonzik-Wang, MD, PhD
Shape Estimation of Soft Manipulator Using Stretchable Sensor
Authors: Jinho So, Uikyum Kim, Yong Bum Kim, Dong-Yeop Seok, Sang Yul Yang, Kihyeon Kim, Jae Hyeong Park, Seong Tak Hwang, Young Jin Gong, Hyouk Ryeol Choi
Journal: Cyborg and Bionic Systems (2021)

The soft robot manipulator is attracting attention in the surgical fields with its intrinsic softness, lightness in its weight, and safety toward the human organ. However, it cannot be used widely because of its difficulty of control. To control a soft robot manipulator accurately, shape sensing is essential. This paper presents a method of estimating the shape of a soft robot manipulator by using a skin-type stretchable sensor composed of a multiwalled carbon nanotube (MWCNT) and silicone (p7670). The sensor can be easily fabricated and applied by simply attaching it to the surface of the soft manipulator. In its fabrication, MWCNT is sprayed on a teflon sheet, and liquid-state silicone is poured on it. After curing, we turn it over and cover it with another silicone layer. The sensor is fabricated with a sandwich structure to decrease the hysteresis of the sensor. After calibration and determining the relationship between the resistance of the sensor and the strain, three sensors are attached at 120° intervals. Using the obtained data, the curvature of the manipulator is calculated, and the entire shape is reconstructed. To validate its accuracy, the estimated shape is compared with the camera data. We experiment with three, six, and nine sensors attached, and the result of the error of shape estimation is compared. As a result, the minimum tip position error is approximately 8.9 mm, which corresponded to 4.45% of the total length of the manipulator when using nine sensors.
KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1
Authors: Wenxue Liu, Zhiyan Zhan, Meiying Zhang, Bowen Sun, Qiqi Shi, Fei Luo, Mingda Zhang, Weiwei Zhang, Yanli Hou, Xiuying Xiao, Yanxin Li, Haizhong Feng
Journal: Theranostics (2021)

Ovarian cancer is a fatal gynecologic malignancy that is found worldwide and exhibits an insidious onset and a lack of early warning symptoms. Despite ongoing studies, the mechanistic basis of the aggressive phenotypes of ovarian cancer remains unclear. Lysine acetyltransferase 6A (KAT6A) is a MYST-type histone acetyltransferase (HAT) enzyme identified as an oncogene in breast cancer, glioblastoma and leukemia. However, the specific functions of KAT6A in ovarian cancer remain unclear.
Immune-Related Adverse Events and Efficacy—The More It Hurts, the Better It Works?—Reply
Authors: Jarushka Naidoo, Jiajia Zhang, Bairavi Shankar
Journal: JAMA Oncology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age ≥70) Is Karyotype Dependent
Authors: Chetasi Talati, Andrew Kuykendall, Najla Al Ali, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, David A Sallman, Alan F. List, Eric Padron, Rami S. Komrokji, Benjamin Djulbegovic, Martine Extermann, Jeffrey E. Lancet, Kendra Sweet
Journal: Blood (2017)
CLINICAL EQUIPOISE FOR SAFE DISCHARGE AFTER 24H IN UNCOMPLICATED INFARCTION WITH ST-ELEVATION: A RETROSPECTIVE STUDY
Authors: Patrick Prud'Homme, Pier-Anne Binette, Louis Verreault-Julien, Marc-Andre D'Entremont, Cédric Marcil, Gabriel Ledoux, Zhi Shuo Zhang, Michel Nguyen, Serge Lepage
Journal: Journal of the American College of Cardiology (2021)
Role of ras protoncogene in survival of patients with lung cancer: a systematic literature review and meta-analysis.
Authors: Céline Mascaux, N Iannino, Benoît Martin, Marianne Paesmans, Thierry Berghmans, Michelle Dusart, Annick Haller, Philippe Lothaire, Anne-Pascale Meert, Jean-Jacques Lafitte, Jean-Paul Sculier
Journal: European Respiratory Journal (2004)
COVID-19–related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters
Authors: Guilherme Dias de Melo, Françoise Lazarini, Sylvain Levallois, Charlotte Hautefort, Vincent Michel, Florence Larrous, Benjamin Verillaud, Caroline Aparicio, Sebastien Wagner, Gilles Gheusi, Lauriane Kergoat, Etienne Kornobis, Flora Donati, Thomas Cokelaer, Rémi Hervochon, Yoann Madec, Emmanuel Roze, Dominique Salmon, Hervé Bourhy, Marc Lecuit, Pierre-Marie Lledo
Journal: Science Translational Medicine (2021)

Whereas recent investigations have revealed viral, inflammatory, and vascular factors involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung pathogenesis, the pathophysiology of neurological disorders in coronavirus disease 2019 (COVID-19) remains poorly understood. Olfactory and taste dysfunction are common in COVID-19, especially in mildly symptomatic patients. Here, we conducted a virologic, molecular, and cellular study of the olfactory neuroepithelium of seven patients with COVID-19 presenting with acute loss of smell. We report evidence that the olfactory neuroepithelium is a major site of SARS-CoV2 infection with multiple cell types, including olfactory sensory neurons, support cells, and immune cells, becoming infected. SARS-CoV-2 replication in the olfactory neuroepithelium was associated with local inflammation. Furthermore, we showed that SARS-CoV-2 induced acute anosmia and ageusia in golden Syrian hamsters, lasting as long as the virus remained in the olfactory epithelium and the olfactory bulb. Last, olfactory mucosa sampling from patients showing long-term persistence of COVID-19-associated anosmia revealed the presence of virus transcripts and of SARS-CoV-2-infected cells, together with protracted inflammation. SARS-CoV-2 persistence and associated inflammation in the olfactory neuroepithelium may account for prolonged or relapsing symptoms of COVID-19, such as loss of smell, which should be considered for optimal medical management of this disease.
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Authors: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Giuseppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, Kevin Punie, Patrick Neven, Abhishek D. Garg, Hans Wildiers, Junbin Qian, Ann Smeets, Diether Lambrechts
Journal: Nature Medicine (2021)
Lung Cancer in Austria
Authors: Robert Pirker, Helmut Prosch, Helmut Popper, Walter Klepetko, Karin Dieckmann, Otto C. Burghuber, Thomas Klikovits, Mir Alireza Hoda, Sabine Zöchbauer-Müller, Martin Filipits
Journal: Journal of Thoracic Oncology (2021)
iPSC–endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension
Authors: Mingxia Gu, Michele Donato, Minzhe Guo, Neil Wary, Yifei Miao, Shuai Mao, Toshie Saito, Shoichiro Otsuki, Lingli Wang, Rebecca L. Harper, Silin Sa, Purvesh Khatri, Marlene Rabinovitch
Journal: Science Translational Medicine (2021)

Drug screening for improved function and transcriptomics of iPSC-derived endothelial cells from patients with pulmonary hypertension reveals AG1296.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia
Authors: Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi, Andrew Brunner, Aaron T. Gerds, Mikkael A. Sekeres, Sudipto Mukherjee, Bruno C. Medeiros, Eunice S. Wang, Pankit Vachhani, Paul J. Shami, Esteban Peña, Mahmoud Elsawy, Kehinde Adekola, Selina Luger, Maria R. Baer, David Rizzieri, Tanya M. Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Wendy Leisenring, Lynn Onstad, Jennifer E. Nyland, Pamela S. Becker, Jeannine S. McCune, Stephanie J. Lee, Brenda M. Sandmaier, Frederick R. Appelbaum, Elihu H. Estey
Journal: Blood (2021)
THE USE OF NATURAL LANGUAGE PROCESSING TOOLS AND THE INTEGRATED ELECTRONIC MEDICAL RECORD (EMR) TO IDENTIFY PATIENTS AT HIGH-RISK FOR TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Authors: Trejeeve Martyn, Joshua Saef, Jerry Estep, Patrick Collier, Deborah Kwon, Wael Jaber, Mazen Hanna, Wai Hong Tang
Journal: Journal of the American College of Cardiology (2021)
EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE
Authors: Julie Kolwelter, Agnes Bosch, Susanne Jung, Peter Linz, Dennis Kannenkeril, Armin M. Nagel, Christian Ott, Peter Bramlage, Michael Uder, Stephan Achenbach, Roland Schmieder
Journal: Journal of the American College of Cardiology (2021)
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation
Authors: Marlou T H F Janssen, Sofia Ramiro, Robert B M Landewé, César Magro-Checa, Rémy L M Mostard
Journal: Annals of the Rheumatic Diseases (2021)

Lettersantibody titres after SARS-CoV-2 vaccination, 1 and it remains unclear how to best interpret the results.The German Rheumatology Association acknowledged in a recent statement that booster vaccinations may have to be considered in patients who do not show sufficiently high or long-lasting titres of neutralising antibodies, 6 but this remains subject to an ongoing debate.Our case demonstrates that booster vaccinations in patients with an initially negative antibody response may induce a positive antibody response even without pausing immunosuppression.
PREVALENCE AND SEVERITY OF CORONARY ARTERY DISEASE ASSESSED BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IN SYMPTOMATIC DIABETIC PATIENTS WITH ZERO CORONARY CALCIUM SCORE
Authors: Francesca Calicchio, Suraj Dahal, Suvasini Lakshmanan, April Kinninger, Rachelle Ann Lopez Gonzales, Amit Johanis, Vikram Muller, Sion Roy, Matthew Budoff
Journal: Journal of the American College of Cardiology (2021)
SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey
Authors: Pablo Garcia, Maria E. Montez-Rath, Heather Moore, Johnie Flotte, Chris Fults, Martha S. Block, Jialin Han, Mary Dittrich, Julie Parsonnet, Glenn M. Chertow, Geoffrey A. Block, Shuchi Anand
Journal: Journal of the American Society of Nephrology (2021)

Patients on dialysis are at increased risk for COVID-19-related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination.With the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons.A total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18-44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18-44 years versus those 45-64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders' main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively).A substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects.This article contains a podcast at https://www.asn-online.org/media/podcast/JASN/2021_07_07_JASN2021010104.mp3.
Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis
Authors: Satoshi Takanashi, Yuko Kaneko, Tsutomu Takeuchi
Journal: Annals of the Rheumatic Diseases (2021)

The advent of biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) has improved the management of rheumatoid arthritis (RA) dramatically. However, there are patients who have not been controlled adequately, and EULAR has recently proposed a definition of difficult-to-treat RA (D2T RA).1 We have verified the definition in our institution, where approximately 60% of 1700 patients with RA have been treated with b/tsDMARDs based on the EULAR recommendation and treat-to-target strategy,2 3 resulting in roughly 85% achieving target (60% in remission and 25% in low disease activity),4 5 and revealed that 10% are classified as D2T RA at the last visit.5 In the process of this investigation, we further identified 77 patients (5%) who were on the borderline of non-D2T RA despite being in moderate or high disease activity due to non-fulfilment of the criterion of failure of two b/tsDMARDs with different mechanisms of action.5 

We compared the characteristics of the 77 non-D2T RA patients in moderate or high disease activity with those of the non-D2T RA patients in remission or low disease activity (table 1). The patients in moderate or high disease …
Health Status and Health Care Use Among Adolescents Identified With and Without Autism in Early Childhood — Four U.S. Sites, 2018–2020
Authors: Patrick S. Powell, Karen Pazol, Lisa D. Wiggins, Julie L. Daniels, Gabriel S. Dichter, Chyrise B. Bradley, Rebecca Pretzel, Joy Kloetzer, Charmaine McKenzie, Alexys Scott, Britney Robinson, Amy S. Sims, Eric P. Kasten, M. Daniele Fallin, Susan E. Levy, Patricia M. Dietz, Mary E. Cogswell
Journal: MMWR Morbidity and Mortality Weekly Report (2021)

Persons identified in early childhood as having autism spectrum disorder (autism) often have co-occurring health problems that extend into adolescence (1-3).Although only limited data exist on their health and use of health care services as they transition to adolescence, emerging data suggest that a minority of these persons receive recommended guidance* from their primary care providers (PCPs) starting at age 12 years to ensure a planned transition from pediatric to adult health care (4,5).To address this gap in data, researchers analyzed preliminary data from a follow-up survey of parents and guardians of adolescents aged 12-16 years who previously participated in the Study to Explore Early Development (https:// www.cdc.gov/ncbddd/autism/seed.html).The adolescents were originally studied at ages 2-5 years and identified at that age as having autism (autism group) or as general population controls (control group).Adjusted prevalence ratios (aPRs) that accounted for differences in demographic characteristics were used to compare outcomes between groups.Adolescents in the autism group were more likely than were those in the control group to have physical difficulties (21.2% versus 1.6%; aPR = 11.6;95% confidence interval [CI] = 4.2-31.9),and to have additional mental health or other conditions † * Recommended guidance on health care transition is defined in the context of three transition elements included in the National Performance Measure of the Health Resources and Services Administration (HRSA) Maternal and Child Health Bureau (MCHB) (https://mchb.tvisdata.hrsa.gov/PrioritiesAndMeasures/NationalPerformanceMeasures).The three elements are 1) time alone, without a parent present, with PCP at last preventive visit; 2) PCP actively worked with child; and 3) parent knows how child will be insured as he or she becomes an adult.Adolescents met the health care transition measure if all three elements were endorsed by the adolescent's parent.https://doi.org/10.
C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation
Authors: Eva Lausberg, Sebastian Gießelmann, Joseph P. Dewulf, Elsa Wiame, Anja Holz, Ramona Salvarinova, Clara D. van Karnebeek, Patricia Klemm, Kim Ohl, Michael Mull, Till Braunschweig, Joachim Weis, Clemens J. Sommer, Stephanie Demuth, Claudia Haase, Claudia Stollbrink-Peschgens, François-Guillaume Debray, Cecile Libioulle, Daniela Choukair, Prasad T. Oommen, Arndt Borkhardt, Harald Surowy, Dagmar Wieczorek, Norbert Wagner, Robert Meyer, Thomas Eggermann, Matthias Begemann, Emile Van Schaftingen, Martin Häusler, Klaus Tenbrock, Lambert van den Heuvel, Miriam Elbracht, Ingo Kurth, Florian Kraft
Journal: Journal of Clinical Investigation (2021)

BACKGROUNDDeciphering the function of the many genes previously classified as uncharacterized open reading frame (ORF) would complete our understanding of a cell's function and its pathophysiology.METHODSWhole-exome sequencing, yeast 2-hybrid and transcriptome analyses, and molecular characterization were performed in this study to uncover the function of the C2orf69 gene.RESULTSWe identified loss-of-function mutations in the uncharacterized C2orf69 gene in 8 individuals with brain abnormalities involving hypomyelination and microcephaly, liver dysfunction, and recurrent autoinflammation. C2orf69 contains an N-terminal signal peptide that is required and sufficient for mitochondrial localization. Consistent with mitochondrial dysfunction, the patients showed signs of respiratory chain defects, and a CRISPR/Cas9-KO cell model of C2orf69 had similar respiratory chain defects. Patient-derived cells revealed alterations in immunological signaling pathways. Deposits of periodic acid-Schiff-positive (PAS-positive) material in tissues from affected individuals, together with decreased glycogen branching enzyme 1 (GBE1) activity, indicated an additional impact of C2orf69 on glycogen metabolism.CONCLUSIONSOur study identifies C2orf69 as an important regulator of human mitochondrial function and suggests that this gene has additional influence on other metabolic pathways.
COVID-19: RACIAL DISPARITY AND CARDIOVASCULAR COMORBIDITIES THAT PREDICT MORTALITY
Authors: Demian Jideofor Omeh, Peter Wenn, Andres Castillo, Ashley Roper, Michelle K. Ponto, Yerin Yang, Yea Wilson, Xiu Qing Lin, Manouchkathe Cassagnol, Ofek Hai, Wenchen Wu, Roman Zeltser, Amgad Makaryus
Journal: Journal of the American College of Cardiology (2021)
A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma
Authors: Vanaja Konduri, Sujith K. Joseph, Tiara T. Byrd, Zeid Nawas, Jonathan Vazquez-Perez, Colby J. Hofferek, Matthew M. Halpert, Dongliang Liu, Zhengdong Liang, Yunyu Baig, Vita S. Salsman, Damilola Oyewole-Said, Anna Tsimelzon, Briana A. Burns, Changyi Chen, Jonathan M. Levitt, Qizhi Yao, Nabil M. Ahmed, Meenakshi Hegde, William K. Decker
Journal: Science Translational Medicine (2021)

A highly cytotoxic T cell memory subset demonstrates intrinsic advantages when used as a CAR T cell platform in a solid tumor model.
Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy
Authors: Jing Ruan, Xiaomin Miao, Dirk Schlüter, Li Lin, Xu Wang
Journal: Molecular Therapy (2021)

Extracellular vesicles (EVs) are bilayer membrane vesicles and act as key messengers in intercellular communication. EVs can be secreted by both neurons and glial cells in the central nervous system (CNS). Under physiological conditions, EVs contribute to CNS homeostasis by facilitating omnidirectional communication among CNS cell populations. In response to CNS injury, EVs mediate neuroinflammatory responses and regulate tissue damage and repair, thereby influencing the pathogenesis, development, and/or recovery of neuroinflammatory diseases, including CNS autoimmune diseases, neurodegenerative diseases, stroke, CNS traumatic injury, and CNS infectious diseases. The unique ability of EVs to pass through the blood-brain barrier further confers them an important role in the bidirectional communication between the CNS and periphery, and application of EVs enables the diagnosis, prognosis, and therapy of neuroinflammatory diseases in a minimally invasive manner.
SHARPEN SCORE ACCURATELY PREDICTS MORTALITY IN SURGICAL AND NON-SURGICAL PATIENTS WITH INFECTIVE ENDOCARDITIS
Authors: Sofia Giusti Alves, Fernando Pivatto, Filippe Barcellos Filippini, Gustavo Paglioli Dannenhauer, Gabriel Seroiska, Helena Marcon Bischoff, Luiz Felipe Schmidt Birk, Diego Terra, Daniel Sganzerla, Marcelo Miglioranza
Journal: Journal of the American College of Cardiology (2021)
Applicability of the Chronic Lymphocytic Leukemia (CLL)-IPI on Patients Treated with Front-Line Ibrutinib in the Real World: The Case for New Prognostic Models
Authors: Danielle M. Brander, Joanna Rhodes, John M. Pagel, Chadi Nabhan, Constantine S. Tam, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Frederick Lansigan, Mazyar Shadman, Chaitra S. Ujjani, Alan P Skarbnik, Bruce D. Cheson, Jeffrey J. Pu, Alison R. Sehgal, Paul M. Barr, John N. Allan, Douglas F. Beach, Bhavisha Patel, Peter V. Pickens, Sunita Dwivedy Nasta, Kaitlin Kennard, Hande H. Tuncer, Brittany Koch, Richard R. Furman, Anthony R. Mato
Journal: Blood (2017)